Authors:
SJOGREN S
INGANAS M
LINDGREN A
HOLMBERG L
BERGH J
Citation: S. Sjogren et al., PROGNOSTIC AND PREDICTIVE VALUE OF C-ERBB-2 OVEREXPRESSION IN PRIMARYBREAST-CANCER, ALONE AND IN COMBINATION WITH OTHER PROGNOSTIC MARKERS, Journal of clinical oncology, 16(2), 1998, pp. 462-469
Authors:
NORBERG T
LENNERSTRAND J
INGANAS M
BERGH J
Citation: T. Norberg et al., COMPARISON BETWEEN P53 PROTEIN MEASUREMENTS USING THE LUMINOMETRIC IMMUNOASSAY AND IMMUNOHISTOCHEMISTRY WITH DETECTION OF P53 GENE-MUTATIONS USING CDNA SEQUENCING IN HUMAN BREAST-TUMORS, International journal of cancer, 79(4), 1998, pp. 376-383
Authors:
WILLIAMS C
NORBERG T
AHMADIAN A
PONTEN F
BERGH J
INGANAS M
LUNDEBERG J
UHLEN M
Citation: C. Williams et al., ASSESSMENT OF SEQUENCE-BASED P53 GENE ANALYSIS IN HUMAN BREAST-CANCER- MESSENGER-RNA IN COMPARISON WITH GENOMIC DNA TARGETS, Clinical chemistry, 44(3), 1998, pp. 455-462
Authors:
FALETTE N
PAPERIN MP
TREILLEUX I
GRATADOUR AC
PELOUX N
MIGNOTTE H
TOOKE N
LOFMAN E
INGANAS M
BREMOND A
OZTURK M
PUISIEUX A
Citation: N. Falette et al., PROGNOSTIC VALUE OF P53 GENE-MUTATIONS IN A LARGE SERIES OF NODE-NEGATIVE BREAST-CANCER PATIENTS, Cancer research, 58(7), 1998, pp. 1451-1455
Authors:
PLATZ A
HANSSON J
MANSSONBRAHME E
LAGERLOF B
LINDER S
LUNDQVIST E
SEVIGNY P
INGANAS M
RINGBORG U
Citation: A. Platz et al., SCREENING OF GERMLINE MUTATIONS IN THE CDKN2A AND CDKN2B GENES IN SWEDISH FAMILIES WITH HEREDITARY CUTANEOUS MELANOMA, Journal of the National Cancer Institute, 89(10), 1997, pp. 697-702
Authors:
SJOGREN S
INGANAS M
NORBERG T
LINDGREN A
NORDGREN H
HOLMBERG L
BERGH J
Citation: S. Sjogren et al., THE P53 GENE IN BREAST-CANCER - PROGNOSTIC VALUE OF COMPLEMENTARY-DNASEQUENCING VERSUS IMMUNOHISTOCHEMISTRY, Journal of the National Cancer Institute, 88(3-4), 1996, pp. 173-182
Authors:
PLATZ A
RINGBORG U
LAGERLOF B
LUNDQVIST E
SEVIGNY P
INGANAS M
Citation: A. Platz et al., MUTATIONAL ANALYSIS OF THE CDKN2 GENE IN METASTASES FROM PATIENTS WITH CUTANEOUS MALIGNANT-MELANOMA, British Journal of Cancer, 73(3), 1996, pp. 344-348
Authors:
JANSSON T
INGANAS M
SJOGREN S
NORBERG T
LINDGREN A
HOLMBERG L
BERGH J
Citation: T. Jansson et al., P53 STATUS PREDICTS SURVIVAL IN BREAST-CANCER PATIENTS TREATED WITH OR WITHOUT POSTOPERATIVE RADIOTHERAPY - A NOVEL HYPOTHESIS BASED ON CLINICAL FINDINGS, Journal of clinical oncology, 13(11), 1995, pp. 2745-2751
Authors:
SEVIGNY P
BJORKESTEN L
PERNEMALM P
INGANAS M
ANDELL Y
ERIKSSON S
NORBERG T
Citation: P. Sevigny et al., EVALUATION OF A LARGE NUMBER OF BREAST-TUMOR SAMPLES PROCESSED BY AUTOMATIC DNA-SEQUENCING OF THE P53 GENE, Clinical chemistry, 41(6), 1995, pp. 221-221
Citation: P. Sevigny et al., ANALYSIS OF MELANOMA SAMPLES BY PCR SSCP AND AUTOMATIC DNA-SEQUENCINGOF THE P16 GENE/, Clinical chemistry, 41(6), 1995, pp. 227-227
Authors:
ANDELI Y
ERIKSSON S
INGANAS M
NORBERG T
SEVIGNY P
Citation: Y. Andeli et al., A NEW APPROACH IN AUTOMATED DNA-SEQUENCING TO ANALYZE THE P53 GENE INA LARGE NUMBER OF BREAST-CANCER PATIENTS, Clinical chemistry, 40(12), 1994, pp. 2337-2337